Changes in cardiovascular responsiveness to dopexamine and β1- and β2-adrenoceptor function after the chronic treatment of β-adrenoceptor antagonists and agonists in anaesthetized dogs

Journal of Autonomic Pharmacology

Volumn 16, Issue 5, 1996, Pages 269-280

  Chang, D H T ^a   Einstein, R ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOPEXAMINE; IMPROMIDINE; ISOPRENALINE; NORADRENALIN; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; FEMALE; HEART MUSCLE CONTRACTILITY; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOGS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; IMPROMIDINE; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1;

EID: 0030459676     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00361.x     Document Type: Article

References (28)

1. BASS, A.S., KOHLI, J.D., LUBBERS, N. & GOLDBERG, L.L. (1987). Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J. Pharmacol. Exp. Ther., 242, 940-944.
2. BLAKE, D.W., WAY, D., TRIGG, L. & MCGRATH, B.P. (1994). Regional blood flow effects of dopexamine vs. enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure. Cardiovasc. Res., 28, 710-714.
3. BOUDOULAS, H., LEWIS, R.P., KATES, R.E. & ALAMANGAS, G. (1977). Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann. Intern. Med., 87, 433-436.
4. BRODDE, O.-E., DAUL, A.E., MARINA, M.-R., BOOMSMA, F., VELD, A.M. & MICHEL, M.C. (1990). Agonist-induced desensitization of β-adrenoceptor function in humans. Circulation, 81, 914-921.
5. 2-adrenoceptors in the human heart: Properties, function and alterations in chronic heart failure. Pharmacol. Rev., 43(2), 203-242.
6. 2-adrenoceptor function. Am. Heart J., 123, 1727-1728.
7. 2-adrenoceptors. Br. J. Pharmacol., 85, 599-608.
8. EINSTEIN, R., MIHAILIDOU, A.S. & RICHARDSON, D.P. (1987). Positive inotropic effects of histamine in anaesthetised dogs. Br. J. Pharmacol., 92, 445-450.
9. EINSTEIN, R., ABDUL-HUSSEIN, N., WONG, T.-W., CHANG, D.H.-T., MATTHEWS, R. & RICHARDSON, D.P. (1994). Cardiovascular actions of dopexamine in anaesthetised and conscious dogs. Br. J. Pharmacol., 111, 199-204.
10. 1-adrenoceptor blockade. Br. J. Pharmacol., 109, 1053-1058.
11. FRANCIS, G.S. & COHN, J.N. (1986). The autonomie nervous system in congestive heart failure. Ann. Rev. Med., 37, 235-247.
12. GOODMAN, A.H., ANGUS, J.A., EINSTEIN, R. & COBBIN, L. B. (1972). A device for measuring myocardial contractility. Med. Biol. Engng., 10, 483-495.
13. 2-adrenoreceptors by atenolol (abstract). Br. J. Pharmacol., 93, 116P.
14. 2-adrenoreceptors in human atrial myocardium. Circ. Res., 66, 1610-1623.
15. 1-antagonist treatment. Circ. Res., 69, 959-964.
16. 2-receptor-mediated responses. Br. J. Pharmacol., 112, 595-603.
17. 2 adrenoreceptors in the human heart by chronic β-adrenoreceptor antagonist treatment. Br. J. Pharmacol., 94, 685-692.
18. MOLENAAR, P., SMOLICH, J.J., RUSSELL, F.D., MCMARTIN, L.R. & SUMMERS, R.J. (1990). Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J. Pharmacol. Exp. Ther., 255, 393-400.
19. 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium. Br. J. Phamacol., 101, 363-369.
20. NANOFF, C., FREISSMUTH, M., TUISL, E. & SCHUTZ, W. (1989). A different desensitization pattern of cardiac β-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J. Cardiovasc. Pharmacol., 13, 198-203.
21. PANFILOV, V., WAHLQVIST, I. & OLSSON, G. (1995). Use of beta-adrenoceptor blockers in patients with congestive heart failure. Cardiovasc. Drugs Ther., 9, 273-287.
22. ROSS, P.J., LEWIS, M.J., SHERIDAN, D.J. & HENDERSON, A.H. (1981). Adrenergic hypersensitivity after beta-blocker withdrawal. Br. Heart J., 45, 637-642.
23. 2-adrenoceptors. J. Auton. Pharmacol. 15, 239-255.
24. 2-adrenoceptors in the dog. J. Pharm. Pharmacol., 39, 636-641.
25. 2-adrenoceptors in the human heart. Eur. Heart J., 10(Suppl. B), 11-22.
26. UEMURA, N., NEJIMA, J., HINTZE, T.H., VATNER, D.E., GRAHAM, R.M., HOMCY, C.J. & VATNER, S.F. (1988). Desensitization to norepinephrine and isoproterenol in conscious dogs. Physiologist, 31, A113.
27. VAN VELDHUISEN, D. J., GIRBES, A. R. J., DE GRAEFF, P. A., & LIE, K. I. (1992). Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure. Int. J. Cardiol., 37, 292-300.
28. WEBB, J.G., NEWMAN, W.H., WALLE, T. & DANIELL, H.B. (1981). Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs. J. Cardiovasc. Pharmacol., 3, 622-635.